Login
CDC Recommends COVID Omicron Booster Shots for Kids as Young as 5 Years Old
The Centers for Disease Control and Prevention on Wednesday recommended the new Omicron boosters for kids as young as age 5, allowing pharmacists to soon start administering the shots.
CDC Director Dr. Rochelle Walensky signed off on the shots just hours after the Food and Drug Administration authorized them. Walensky made the swift decision without a meeting of the CDC’s independent panel of vaccine experts.
Children ages 5 to 11 are eligible for Pfizer’s Omicron shots and kids ages 6 through 17 are eligible for Moderna’s shots two months after receiving their primary series or previous booster with the first-generation vaccines.
Pharmacies can start administering the shots as soon they have doses. Pfizer said it will ship to up 6 million booster doses for kids within the next week, according to a company statement.
Former French Presidential Candidate Says COVID Vaccine ‘Almost Killed Me’
A former French presidential candidate claimed that he underwent several operations and nearly died after receiving the COVID-19 vaccine.
Jean Lassalle told NTD Television, a sister media of The Epoch Times, that he underwent four operations since January 2022 and blamed the COVID-19 vaccine, saying it nearly killed him after it “distorted his heart.” Lassalle represented the fourth constituency of the Pyrenees-Atlantiques department in the National Assembly for several decades before he ran for president.
When asked why he took the COVID-19 shot, he said that he was a member of Parliament and “didn’t want to give the feeling that I wasn’t doing my job” before alleging that French President Emmanuel Macron “was not vaccinated.” He did not elaborate.
Can’t Make This Up — Moderna CEO Announces Development of New mRNA ‘Injection’ to Repair Heart Muscle After a Heart Attack
Ever since the experimental COVID-19 vaccine’ was introduced, a staggering and horrifying phenomenon has been sweeping the Western world. We have seen it happen to athletes, performers, musicians, news anchors, soldiers, high schoolers, healthcare workers, random people, politicians and so on. People have been dropping to the ground like flies because of heart-related issues that are, in virtually every case, caused by an adverse reaction to the mRNA jab.
It’s undeniable; the rise in these life-threatening incidents has a clear and proven culprit (as numerous studies have shown a clear link between the mRNA spike protein and the litany of complications that are arising). not only that, but people are dying at an unprecedented rate. The evidence has become so overwhelming that, as of this week, Florida’s Surgeon General has even come out and recommended that people refrain from taking the vaccine because it causes a massive 84% spike in cardiac-related death in males aged 18-39.
This week, the vaccine maker Moderna officially announced it has developed a ‘cure’ for the tyrannical medical-industrial complex’s latest manufactured health crisis.
In the wake of all of the cardiac-related death and sickness caused by the first iterations of the experimental mRNA vaccine, Moderna CEO Stéphane Bancel revealed the company’s new treatment for heart attacks — another mRNA injection! This time, however, instead of going into your arm, it will be shot directly into the heart muscle… For maximum damage effect, of course.
Merck Opts to Develop, Sell Cancer Vaccine With Moderna
Merck & Co Inc. (MRK.N) opted to jointly develop and potentially sell a personalized mRNA vaccine with Moderna Inc. (MRNA.O) for a $250 million upfront payment on Wednesday, sending the vaccine maker’s shares up over 8%.
Moderna’s experimental vaccine is being tested in combination with Merck’s blockbuster cancer immunotherapy, Keytruda, in a mid-stage trial to treat patients with melanoma. Data on the vaccine, mRNA-4157, is expected in the fourth quarter of this year.
With the size of the COVID-19 vaccine market expected to contract in subsequent years from the levels seen in 2021, Moderna has been pinning its hopes on its non-COVID vaccines which include influenza and respiratory syncytial virus shots.
The cancer vaccine is tailored for each patient to generate T-cells, a key part of the body’s immune response, based on the specific mutational signature of a tumor. In 2016, Merck and Moderna entered a strategic partnership to develop a personalized vaccine for the treatment of various types of cancer.
‘Scandalous’: Pfizer Exec Tells EU Lawmaker COVID Jab Was Never Tested to Show It Blocked Transmission
A top Pfizer executive’s admission Monday to European lawmakers that the pharmaceutical giant never tested its COVID vaccine to determine if it stopped transmission is raising new questions about the global effort to compel people to get the jabs.
Janine Small, Pfizer’s president of international developed markets, made the stunning admission while testifying before the European Union Parliament. She was asked by European Union Member of Parliament Rob Roos if the company tested its mRNA vaccine on stopping transmission before rolling it out.
Small, who was sent to testify when Pfizer CEO Albert Bourla declined, said the company didn’t have time to see if its vaccine would stop the spread of COVID. She said no such tests were conducted because the world was facing a health crisis, and insisted that the vaccine, which Pfizer believes protects people from getting COVID, or at least makes it less deadly if they do, had to be made quickly available.
Roos, who represents the Netherlands, later shared a clip of Small’s response on Twitter and said it showed that the global campaign to force vaccination to protect others was built on a lie.
What Is XBB? The New ‘Immune-Evasive’ COVID Strain That Combines Omicron Variants Is Driving Cases in Two Countries
New variants of the rapidly mutating coronavirus are still popping up around the world, and a new iteration of COVID on the rise in Asia may be the most immune-evasive yet.
The XBB strain is causing a small surge in cases in countries like Bangladesh and Singapore. The latter has recorded a daily average of about 5,500 cases over the past week, compared to a daily average of 2,000 cases a month ago.
Experts are paying close attention to the XBB strain, which combines two different Omicron strains. Eric Topol, the founder of the Scripps Research Translational Institute, tweeted that XBB is one “of the most important variants [to] watch right now.”
White House: Get New Booster by Halloween for Safer Holidays
The White House on Tuesday said eligible Americans should get the updated COVID-19 boosters by Halloween to have maximum protection against the coronavirus by Thanksgiving and the holidays, as it warned of a “challenging” virus season ahead.
So far the Centers for Disease Control and Prevention says only about 11.5 million Americans have received the updated shots, which are meant to provide a boost of protection against both the original strain of COVID-19 and the BA.5 variant that is dominant around the world.
Dr. Ashish Jha, the White House COVID-19 coordinator, criticized Congress, which has refused the White House’s $22 billion budget request for virus response, saying that has kept the U.S. from building a stockpile of tests to use in the event of a new winter surge.
Europe Likely Entering Another COVID Wave, Says WHO and ECDC
Another wave of COVID-19 infections may have begun in Europe as cases begin to tick up across the region, the World Health Organization and European Centre for Disease Prevention and Control (ECDC) said on Wednesday.
“Although we are not where we were one year ago, it is clear that the COVID-19 pandemic is still not over,” WHO’s Europe director, Hans Kluge, and ECDC’s director, Andrea Ammon, said in a joint statement.
WHO’s region-wise data showed that only Europe recorded a rise in COVID-19 cases in the week ended Oct. 2, clocking an increase of 8% from the prior week.
Public health experts have warned that vaccine fatigue and confusion over available vaccines will likely limit booster uptake in the region
Vaccine Trials on Sudan Ebola Strain to Start in Weeks — WHO Chief
World Health Organization head Tedros Adhanom Ghebreyesus said on Wednesday a clinical trial of vaccines that could potentially combat the Sudan strain of Ebola driving an outbreak in Uganda could start within weeks.
The East African country declared an outbreak of Ebola on Sept. 20 and said infections were being caused by the Sudan strain. Uganda’s health ministry has confirmed a total of 54 Ebola cases and 19 deaths.
In a virtual address to a meeting of African regional health officials in Uganda’s capital Kampala, Tedros said several vaccines are currently being developed that could deal with the Sudan strain.
Tedros did not give details of the vaccines due for trial including their names or which firms developed them.
